Marco Ronzoni

421 total citations
8 papers, 139 citations indexed

About

Marco Ronzoni is a scholar working on Pathology and Forensic Medicine, Oncology and Rheumatology. According to data from OpenAlex, Marco Ronzoni has authored 8 papers receiving a total of 139 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Pathology and Forensic Medicine, 2 papers in Oncology and 2 papers in Rheumatology. Recurrent topics in Marco Ronzoni's work include Multiple Sclerosis Research Studies (5 papers), Cell Adhesion Molecules Research (2 papers) and Peripheral Neuropathies and Disorders (1 paper). Marco Ronzoni is often cited by papers focused on Multiple Sclerosis Research Studies (5 papers), Cell Adhesion Molecules Research (2 papers) and Peripheral Neuropathies and Disorders (1 paper). Marco Ronzoni collaborates with scholars based in Italy, Denmark and Lebanon. Marco Ronzoni's co-authors include Elio Scarpini, Daniela Galimberti, Raffaella Clerici, Giancarlo Conti, Pierluigi Baron, G. Scarlato, Nereo Bresolin, Milena De Riz, E. Venturelli and Cristoforo Comi and has published in prestigious journals such as Biochemical and Biophysical Research Communications, Journal of the Neurological Sciences and Neuroscience Letters.

In The Last Decade

Marco Ronzoni

6 papers receiving 133 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Marco Ronzoni Italy	4	57	56	33	31	30	8	139
David A. Hafler United Kingdom	2	117 2.1×	126 2.3×	28 0.8×	51 1.6×	45 1.5×	2	236
Claudia Janoschka Germany	6	42 0.7×	32 0.6×	14 0.4×	32 1.0×	9 0.3×	7	95
Andrea Flierl‐Hecht Germany	6	66 1.2×	63 1.1×	13 0.4×	50 1.6×	14 0.5×	7	150
Lisa Lohmann Germany	5	50 0.9×	27 0.5×	16 0.5×	19 0.6×	12 0.4×	7	91
José Vicente Hervás Spain	9	115 2.0×	53 0.9×	42 1.3×	85 2.7×	14 0.5×	20	220
Tai Wai Yeo Singapore	4	53 0.9×	50 0.9×	10 0.3×	15 0.5×	14 0.5×	8	98
Katherine A. McLaughlin United States	3	48 0.8×	122 2.2×	29 0.9×	18 0.6×	14 0.5×	4	164
Kerry Naunton United States	3	118 2.1×	41 0.7×	29 0.9×	16 0.5×	14 0.5×	3	139
Bianca Weinstock-Guttman United States	6	79 1.4×	12 0.2×	21 0.6×	19 0.6×	25 0.8×	10	115
Ann Seman United States	5	42 0.7×	61 1.1×	33 1.0×	97 3.1×	2 0.1×	5	215

Countries citing papers authored by Marco Ronzoni

Since Specialization

Citations

This map shows the geographic impact of Marco Ronzoni's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marco Ronzoni with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marco Ronzoni more than expected).

Fields of papers citing papers by Marco Ronzoni

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marco Ronzoni. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marco Ronzoni. The network helps show where Marco Ronzoni may publish in the future.

Co-authorship network of co-authors of Marco Ronzoni

This figure shows the co-authorship network connecting the top 25 collaborators of Marco Ronzoni. A scholar is included among the top collaborators of Marco Ronzoni based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marco Ronzoni. Marco Ronzoni is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

1.

Nociti, Viviana, Marina Romozzi, Pietro Annovazzi, et al.. (2025). Effectiveness, safety, and impact on multiple sclerosis course of anti-CGRP monoclonal antibodies. Journal of the Neurological Sciences. 469. 123392–123392. 1 indexed citations

2.

Giossi, Riccardo, Massimo Filippi, Chiara Zanetta, et al.. (2024). Unprescribed cannabinoids and multiple sclerosis: a multicenter, cross-sectional, epidemiological study in Lombardy, Italy. Journal of Neurology. 271(11). 7186–7205.

3.

Clerici, Valentina Torri, Laura Brambilla, Simone Tonietti, et al.. (2023). Nabiximols oromucosal spray in patients with multiple sclerosis-related bladder dysfunction: A prospective study. Multiple Sclerosis and Related Disorders. 74. 104711–104711. 2 indexed citations

4.

Ronchi, Dario, Andreina Bordoni, Mafalda Rizzuti, et al.. (2011). Unusual adult-onset Leigh syndrome presentation due to the mitochondrial m.9176T>C mutation. Biochemical and Biophysical Research Communications. 412(2). 245–248. 12 indexed citations

5.

Prodi, Giorgio & Marco Ronzoni. (2006). A volte producono: le imprese italiane in Cina. Electronic Markets.

6.

Scalabrini, D., Daniela Galimberti, Chiara Fenoglio, et al.. (2005). P-selectin glycoprotein ligand-1 variable number of tandem repeats (VNTR) polymorphism in patients with multiple sclerosis. Neuroscience Letters. 388(3). 149–152. 12 indexed citations

7.

Galimberti, Daniela, Chiara Fenoglio, Raffaella Clerici, et al.. (2005). E-selectin A561C and G98T polymorphisms influence susceptibility and course of multiple sclerosis. Journal of Neuroimmunology. 165(1-2). 201–205. 17 indexed citations

8.

Scarpini, Elio, Daniela Galimberti, Pierluigi Baron, et al.. (2002). IP-10 and MCP-1 levels in CSF and serum from multiple sclerosis patients with different clinical subtypes of the disease. Journal of the Neurological Sciences. 195(1). 41–46. 95 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact